Although the present study only included adults aged over 18, a nationwide study conducted in Iran indicated that MetS and some cardiometabolic risk factors were significantly associated with ALT levels in children and adolescents aged 7–18 years [30]. The gene discussed is GPT; the disease is metabolic syndrome.